Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"Cruzain"”.

  1. Inhibitors of human cathepsin L and cruzain as therapeutic agents.

    … research project consisted of recombinant cruzain purification and evaluation of thiosemicarbazone derivatives as potential inhibitors of this parasitic cysteine protease. Cruzain is the major cysteine protease of Trypanosoma cruzi organism and is a validated therapeutic target for the …

    baylor Repository record for Inhibitors of human cathepsin L and cruzain as therapeutic agents. (opens in a new tab)

  2. Modeling, design, and development of potential inhibitors of γ-glutamylamine cyclotransferase and inhibitors of cruzain as therapeutic agents for Chagas' disease.

    … 4-thiochromenone was evaluated for inhibition of cruzain, a cloned version of cruzipain. Kinetics studies and molecular modeling was used to gain understanding of enzyme-inhibitor interactions. The best compounds, the TSC derivatives of a dibromobenzophenone and a bromo-α-tetralone were found to …

    baylor Repository record for Modeling, design, and development of potential inhibitors of γ-glutamylamine cyclotransferase and inhibitors of cruzain as therapeutic agents for Chagas' disease. (opens in a new tab)

  3. Design, synthesis and evaluation of di-nitrogen derivatives of combretastatin and novel cruzain inhibiting compounds for the treatment of Chagas disease.

    … been focused on the design and synthesis of new cruzain inhibitors modeled around an initial small library of molecules previously prepared by the Pinney Research Group at Baylor University. These thiosemicarbazone bearing molecules were designed to target the major cysteine protease of …

    baylor Repository record for Design, synthesis and evaluation of di-nitrogen derivatives of combretastatin and novel cruzain inhibiting compounds for the treatment of Chagas disease. (opens in a new tab)

  4. The Development of Targeted Cysteine Protease Inhibitors Through Rational Design: Structural, Kinetic, and Activity Analysis of Ligand-Target Interactions

    … cysteine proteases human cathepsin L (hCatL) and cruzain are two members of the C1 family of cysteine proteases characterized by the prototypic family member papain and share high similarity in both active site structure and substrate preference between themselves. Both proteins have been …

    tamu Repository record for The Development of Targeted Cysteine Protease Inhibitors Through Rational Design: Structural, Kinetic, and Activity Analysis of Ligand-Target Interactions (opens in a new tab) Embargoed until 2028-05-01

  5. The Development of Targeted Cysteine Protease Inhibitors Through Rational Design: Structural, Kinetic, and Activity Analysis of Ligand-Target Interactions

    … cysteine proteases human cathepsin L (hCatL) and cruzain are two members of the C1 family of cysteine proteases characterized by the prototypic family member papain and share high similarity in both active site structure and substrate preference between themselves. Both proteins have been …

    tamu Repository record for The Development of Targeted Cysteine Protease Inhibitors Through Rational Design: Structural, Kinetic, and Activity Analysis of Ligand-Target Interactions (opens in a new tab) Embargoed until 2028-05-01

  6. The Development of Targeted Cysteine Protease Inhibitors Through Rational Design: Structural, Kinetic, and Activity Analysis of Ligand-Target Interactions

    … cysteine proteases human cathepsin L (hCatL) and cruzain are two members of the C1 family of cysteine proteases characterized by the prototypic family member papain and share high similarity in both active site structure and substrate preference between themselves. Both proteins have been …

    tamu Repository record for The Development of Targeted Cysteine Protease Inhibitors Through Rational Design: Structural, Kinetic, and Activity Analysis of Ligand-Target Interactions (opens in a new tab) Embargoed until 2028-05-01

  7. Design, synthesis and biological evaluation of new anti-cancer nitrogen-containing combretastatins and novel cysteine protease inhibitors for the treatment of Chagas.

    … primarily focused toward the inhibition of cruzain, the major cysteine protease of Trypanosoma cruzi which is the agent of the parasitic disease called Chagas' disease. Currently there is no satisfactory treatment for this disease, and the two accepted drugs, nifurtimox and benznidazole, are …

    baylor Repository record for Design, synthesis and biological evaluation of new anti-cancer nitrogen-containing combretastatins and novel cysteine protease inhibitors for the treatment of Chagas. (opens in a new tab)

  8. Kinetic characterization of thiosemicarbazones as cysteine protease inhibitors and their potential use as therapeutic agents against metastatic cancer and Chagas' disease.

    … of preventing cancer metastasis. In addition, cruzain, a cathepsin L-like cysteine protease found in Trypanosoma cruzi, is a validated target for pivotal roles in the parasitic invasion in Chagas' disease, a condition that could be fatal if not treated. Currently, there is no effective …

    baylor Repository record for Kinetic characterization of thiosemicarbazones as cysteine protease inhibitors and their potential use as therapeutic agents against metastatic cancer and Chagas' disease. (opens in a new tab)

  9. Design and Development of Two Novel Classes of Cysteine Protease Inhibitors against Pathogenic Trypanosomes

    … is a well characterized covalent inactivator of cruzain, the major cysteine protease of Trypanosoma cruzi. However, its irreversible mode of action may be associated with safety issues that impede its progression to clinical trials. We designed and synthesized a novel class of peptidomimetic …

    tamu Repository record for Design and Development of Two Novel Classes of Cysteine Protease Inhibitors against Pathogenic Trypanosomes (opens in a new tab)

  10. Drug Discovery and Kinetics in Mycobacterium Tuberculosis, Trypanosoma Cruzi, and SARS-CoV-2

    … developing inhibitors of the cysteine protease cruzain, from Trypanosoma cruzi, we synthesized and kinetically characterized fluorogenic dipeptide substrates. Upon appending a fixed electrophilic warhead to our varied peptide scaffolds, we identified a linear correlation between the Km of our …

    tamu Repository record for Drug Discovery and Kinetics in Mycobacterium Tuberculosis, Trypanosoma Cruzi, and SARS-CoV-2 (opens in a new tab)

  11. Synthese und Testung neuartiger peptidomimetischer, selektiver Inhibitoren parasitärer Cystein-Proteasen

    … K, Cathepsin S, LmCPB2.8, LmajcatB, Rhodesain, Cruzain und Falcipain-2 auf ihre inhibitorische Aktivität getestet. Weiterhin wurden die Verbindungen im Rahmen der interdisziplinären Zusammenarbeit innerhalb des Sonderforschungsbereichs 630 auf ihre antiparasitäre Aktivität an Leishmanien, …

    wurz-thes Repository record for Synthese und Testung neuartiger peptidomimetischer, selektiver Inhibitoren parasitärer Cystein-Proteasen (opens in a new tab)

  12. Applications of Molecular Modelling and Structure Based Drug Design in Drug Discovery

    … discovery approach was chosen for this disease. Cruzain is the major etiologic enzyme involved in the disease and is only present in the parasite. It is also an enzyme expressed by the parasite in both phases. Herein, a novel peptoid library containing hydromethylketones was constructed and …

    usf Repository record for Applications of Molecular Modelling and Structure Based Drug Design in Drug Discovery (opens in a new tab)

  13. Characterization of irreversible inhibition of proteases by mass spectroscopy

    … serine protease trypsin, the cysteine protease cruzain, and the aspartic proteases, HIV-2 protease and SIV protease, were covalently modified only at one amino acid residue, while the aspartic protease, HIV-1 protease, was found to be modified at three sites by the haloperidol derivative …

    u-pacific Repository record for Characterization of irreversible inhibition of proteases by mass spectroscopy (opens in a new tab)

  14. Synthesis of new chiral pyrylium salts, the corresponding phosphinine and pyridine derivatives and the kinetic studies of the epimerization of pyrylium salts.

    … moiety. The cytotoxicity and inhibition of cruzain were evaluated and found to be non-actives. Our interest in chiral pyrylium salts led us to investigate the configurational stability of chiral centers alpha to the pyrylium ring. Although no epimerizable (or even racemizable) pyrylium salts …

    baylor Repository record for Synthesis of new chiral pyrylium salts, the corresponding phosphinine and pyridine derivatives and the kinetic studies of the epimerization of pyrylium salts. (opens in a new tab)

  15. Design, synthesis and evaluation of cysteine protease inhibitors

    … inhibitors for the parasitic cysteine proteases; cruzain, rhodesain. We have found that monosubstituted amides were favored over disubstituted amides indicating the involvement of the amide hydrogen in a H-bond network. We have shown that aza-peptide epoxides were as potent as Michael acceptors …

    gatech Repository record for Design, synthesis and evaluation of cysteine protease inhibitors (opens in a new tab)

  16. Preclinical characterization of small molecule compounds as therapeutics for cancer and Chagas' disease : tumor vascular disrupting agents and cysteine protease inhibitors.

    … metastasis. In addition, the cysteine protease cruzain, an essential enzyme in the life cycle of parasite Trypanosoma cruzi, is a validated therapeutic target for Chagas' disease. In this project, preliminary in vitro analysis of a group of synthetic thiosemicarbazones were carried out in order …

    baylor Repository record for Preclinical characterization of small molecule compounds as therapeutics for cancer and Chagas' disease : tumor vascular disrupting agents and cysteine protease inhibitors. (opens in a new tab)

  17. Theoretical investigations of proton transfer and interactions or reactions of covalent and non-covalent inhibitors in different proteins

    … concerning cysteine proteases such as cruzain and rhodesain have been conducted with respect to experimental kinetic data of covalent vinylsulfone inhibitors. Several approaches such as QM or QM/MM calculations and docking, MD or MMPBSA/MMGBSA simulations have been applied to reproduce …

    wurz-thes Repository record for Theoretical investigations of proton transfer and interactions or reactions of covalent and non-covalent inhibitors in different proteins (opens in a new tab)

  18. Síntese de compostos heterocíclicos quirais e aquirais inibidores de cruzaína e rodesaína : potenciais agentes para tratamento de tripanossomíases

    A Doença de Chagas e a Tripanossomíase Africana (HAT) são doenças negligenciadas, cujos agentes etiológicos são Trypanosoma cruzi e Trypanosoma brucei, respectivamente. Um dos alvos validados para o desenvolvimento de medicamentos para o tratamento dessas doenças são as proteases, como a cruzaína, …

    brazil-ufrgs Repository record for Síntese de compostos heterocíclicos quirais e aquirais inibidores de cruzaína e rodesaína : potenciais agentes para tratamento de tripanossomíases (opens in a new tab)

Page 1 of 2